Show simple item record

dc.contributor.authorChater, Angel M.en
dc.contributor.authorParham, Rhianen
dc.contributor.authorRiley, Steveen
dc.contributor.authorHutchison, Alastair J.en
dc.contributor.authorHorne, Roberten
dc.date.accessioned2017-10-24T13:06:32Z
dc.date.available2017-10-24T13:06:32Z
dc.date.issued2014-07-11
dc.identifier.citationChater A., Parham R., Riley S., Hutchison A., Horne R. (2014) 'Profiling patient attitudes to phosphate binding medication: a route to personalising treatment and adherence support', Psychology and Health, 29 (12), pp.1407-1420.en
dc.identifier.issn0887-0446
dc.identifier.pmid25012529
dc.identifier.doi10.1080/08870446.2014.942663
dc.identifier.urihttp://hdl.handle.net/10547/622310
dc.description.abstractObjective: Nonadherence to phosphate binding medication (PBM) compromises the efficacy of treatment for chronic kidney disease, but its causes are poorly understood. This study sought to explore patient attitudes towards PBM and to evaluate the utility of the necessity-concerns framework for understanding adherence to PBM. Design: A sample of 221 dialysis patients currently prescribed PBM were surveyed from eight UK renal units. Main Outcome Measures: Demographic data and clinical information, alongside the Beliefs about Medicines Questionnaire and the medication adherence report scale were reported. Results: Low adherence to PBM was predicted by reduced beliefs in personal need for PBM (OR = .34; 95% CI: .14–.83; p < .05), and increased concerns about PBM (OR = 3.17; 95% CI: 1.87–5.37; p < .001). Patients were categorised into attitudinal groups based on their beliefs about PBM and being ‘skeptical’ of PBM (low necessity beliefs and high concerns) was most associated with low adherence. Conclusion: Strategies to improve adherence to PBM should aim to elicit and address patients’ beliefs about their personal need for PBM and their concerns about this medication.
dc.language.isoenen
dc.publisherRoutledgeen
dc.relation.urlhttp://www.tandfonline.com/doi/abs/10.1080/08870446.2014.942663en
dc.rightsGreen - can archive pre-print and post-print or publisher's version/PDF
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectnonadherenceen
dc.subjectbeliefsen
dc.subjectchronic kidney diseaseen
dc.subjectphosphate binding medicationen
dc.subjectattitudesen
dc.subjectC841 Health Psychologyen
dc.titleProfiling patient attitudes to phosphate binding medication: a route to personalising treatment and adherence supporten
dc.typeArticleen
dc.identifier.journalPsychology and Healthen
dc.date.updated2017-10-24T11:29:02Z
html.description.abstractObjective: Nonadherence to phosphate binding medication (PBM) compromises the efficacy of treatment for chronic kidney disease, but its causes are poorly understood. This study sought to explore patient attitudes towards PBM and to evaluate the utility of the necessity-concerns framework for understanding adherence to PBM. Design: A sample of 221 dialysis patients currently prescribed PBM were surveyed from eight UK renal units. Main Outcome Measures: Demographic data and clinical information, alongside the Beliefs about Medicines Questionnaire and the medication adherence report scale were reported. Results: Low adherence to PBM was predicted by reduced beliefs in personal need for PBM (OR = .34; 95% CI: .14–.83; p < .05), and increased concerns about PBM (OR = 3.17; 95% CI: 1.87–5.37; p < .001). Patients were categorised into attitudinal groups based on their beliefs about PBM and being ‘skeptical’ of PBM (low necessity beliefs and high concerns) was most associated with low adherence. Conclusion: Strategies to improve adherence to PBM should aim to elicit and address patients’ beliefs about their personal need for PBM and their concerns about this medication.


Files in this item

Thumbnail
Name:
Chateretal2014-Profilingpatien ...
Size:
219.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Green - can archive pre-print and post-print or publisher's version/PDF
Except where otherwise noted, this item's license is described as Green - can archive pre-print and post-print or publisher's version/PDF